SCHEMBL26326700

SCHEMBL26326700

Cc1ccc(S(=O)(=O)Oc2ccc3cc(-c4ccc(F)cc4)ccc3c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.60
CA2 P00918 6/20 0.60
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
L3MBTL1 Q9Y468 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
HTT P42858 2/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 1/20 0.47
MAPK1 P28482 1/20 0.47
CNR2 P34972 1/20 0.46
ENPP2 Q13822 1/20 0.44
ENPP3 O14638 1/20 0.44
ENPP1 P22413 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
AKR1C3 P42330 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793395 0.88 MEN1 (0.65) CA12CA2MEN1KMT2AL3MBTL1
SCHEMBL4950065 0.86 MEN1 (0.70) CA12CA2MEN1KMT2AL3MBTL1
SCHEMBL4126119 0.83 AKR1C3 (0.55) CA12CA2MEN1KMT2AHTT
SCHEMBL22558454 0.83 AKR1C3 (0.55) CA12CA2MEN1KMT2AHTT
SCHEMBL8794066 0.82 MEN1 (0.82) CA12CA2MEN1KMT2AL3MBTL1
SCHEMBL6937173 0.80 CA2 (0.64) CA12CA2MEN1KMT2AHTT
SCHEMBL29870275 0.79 L3MBTL1 (0.77) CA12CA2MEN1KMT2AL3MBTL1
SCHEMBL6882887 0.79 L3MBTL1 (0.77) CA12CA2MEN1KMT2AL3MBTL1
SCHEMBL26326698 0.79 L3MBTL1 (0.71) CA12CA2MEN1KMT2AL3MBTL1
SCHEMBL13629814 0.78 ACHE (0.59) MEN1KMT2ALMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271988-A1 METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE HPD, TALDO1, OGG1 CA12 2312/4885CA2 1809/4885MEN1 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.